A positive screening result is presumptive, not proof. If you get a non-negative result, the single most important move is to preserve your prescriptions and medical records and contact the testing program or Medical Review Officer right away to request confirmatory or split-specimen testing before anything is finalized.
TL;DR:
- Immunoassay screens can react to medications because they detect shared chemical structures; confirmatory testing with mass spectrometry can distinguish substances more specifically.
- A single 400 mg ofloxacin pill triggered a false positive opiate result on the EMIT II immunoassay, while poppy seeds and diphenhydramine can also interfere.
- In many regulated programs, you have commonly 72 hours after notification to request split specimen testing at a second certified laboratory.
- Give the Medical Review Officer prescription and medical records, and ask which assay and cutoff were used; those details can explain an unexpected screen.
Immunoassay screens work by using antibodies that bind to a general chemical structure shared by a class of drugs. That design makes them fast and cheap, but it also makes them prone to flagging substances that merely resemble the target molecule. According to NIDA, initial immunoassays are rapid presumptive screens with high sensitivity and a known risk of cross-reactivity, which is exactly why they are treated as triggers for further testing rather than final answers.

Confirmatory testing uses methods such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). These techniques can help distinguish substances that an antibody-based screen may confuse.
A few other factors shape whether a screen throws a false flag:
This two-tier system, screen first, confirm second, exists because speed and specificity pull in opposite directions, and no single test does both well.
A wide list of ordinary medications, foods, and products has been tied to false-positive immunoassay results in published case reports and clinical reviews. Knowing the usual suspects helps you figure out what documentation to pull together.
A clinical review of opiate testing notes that false positives commonly trace back to cross-reactivity from drugs including quinolones, rifampin, verapamil, quetiapine, and diphenhydramine, alongside inadvertent exposures like poppy seeds, and that confirmatory GC-MS testing is what ultimately separates true positives from these false flags.
None of this means a positive screen is automatically wrong. It means a screen alone cannot tell you whether a result reflects an actual drug or an everyday medication doing exactly what it was prescribed to do.
Not every screening category carries the same false-positive risk. Some drug classes have a long, documented history of cross-reactivity, while others rarely produce surprises.
An ACMT position statement on opiate testing makes the underlying point clear: immunoassay false positives are antibody cross-reactivity events that are both assay-dependent and concentration-dependent, so consulting the laboratory or the assay’s own documentation is often the fastest way to understand an unexpected result. When a screen flags something that does not match your history, the question is rarely “is the test broken,” it is “does this particular assay react to something I’m actually taking.”
A non-negative screen is not the end of the process. It sets off a defined sequence designed to separate real findings from interference.
The split specimen itself is simply a backup portion of your original sample, set aside at collection so that a second lab can run its own independent confirmatory analysis if you request it.
Pro Tip: Ask the MRO directly which assay and cutoff were used on your screen, since that single detail often explains why a common medication triggered the flag.
The final outcome lands in one of a few categories: reconfirmed positive, failed to reconfirm (the result is canceled), or invalid, adulterated, or substituted, each of which carries different next steps and different implications for how the result gets reported.
Act promptly after a non-negative result. A clear paper trail is often the difference between a quick resolution and a prolonged dispute.
Most public conversation about drug testing treats a positive result as a verdict, when it is really the first step in a two-part process built specifically because that first step is imprecise. The bigger misunderstanding is not about any one medication, it is about what “positive” is even supposed to mean at the screening stage. An immunoassay is a filter, not a verdict, and treating it otherwise causes most of the unnecessary panic and unfair outcomes connected to these programs.
A practical response is to gather your documentation, check the applicable timeline, and ask about confirmatory testing. People who understand that distinction tend to navigate a non-negative result calmly, while people who do not often accept a presumptive flag as final when they never had to.
— MIchael
Documenting a presumptive positive gets easier when you know exactly what to ask for and where to look next. Our guide on probation drug tests and GC/MS confirmation walks through the specific language to use when requesting confirmatory testing in a supervised setting, and it pairs well with the procedural steps above if your situation involves a court or probation program.

Beyond individual guides, our membership programs connect nursing professionals and students with educational resources and opportunities for questions that go beyond a single article. Options include:
If you want a closer look at what membership includes, visit our membership page to see current options and sign up.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Yes. You have the right to request confirmatory testing and, in many regulated programs, split-specimen testing at a second certified lab within the window your program allows. Providing documentation of prescriptions or relevant medical history to the Medical Review Officer is typically how a disputed result gets resolved.
Documented examples include the antibiotic ofloxacin triggering false-positive opiate results, along with certain antidepressants, decongestants like pseudoephedrine, some NSAIDs, and poppy seed ingestion. Which drugs cross-react depends heavily on the specific immunoassay platform used.
Immunoassay screens detect a general chemical structure shared by a class of drugs, so a prescription medication or over-the-counter product can sometimes bind to the same antibody and trigger a flag. A clinical review of opiate testing confirms this cross-reactivity is a well-documented cause of unexpected screening results, which is exactly why confirmatory testing exists.
Immediately gather your prescriptions, medication list, and any relevant medical documentation, then contact the Medical Review Officer to request confirmatory or split-specimen testing. Follow up by asking which assay and cutoff were used, since that detail often explains the result.